Burden of Infection in Primary Antibody Deficiency (BIPAD) Study
Research type
Research Study
Full title
This study aims to define the burden of upper respiratory viral infection in a large sample of antibody deficient patients over the course of 1 year.
IRAS ID
179876
Contact name
Stephen Jolles
Contact email
Sponsor organisation
Cardiff & Vale University Health Board, NHS Wales
Duration of Study in the UK
2 years, 0 months, 28 days
Research summary
Despite immunoglobulin replacement therapy, patients with primary antibody deficiency appear to be at increased risk of repeated respiratory tract infections. There is little research available in this field. This study aims to better characterise the nature, frequency and severity of these in a UK population.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
15/NW/0379
Date of REC Opinion
7 May 2015
REC opinion
Further Information Favourable Opinion